Other

Conversion of other receivable in exchange for research and development services to subscription receivable

Year-over-year, this metric declined by 100.0%, from $233.00K to $0.00.

Analysis

StatementCash Flow Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ4 2025Mar 30, 2026

How to read this metric

An increase may indicate a strategic shift toward subscription-based business models, while frequent reclassifications could suggest volatility in contract structures or revenue recognition timing.

Detailed definition

This metric represents the non-cash reclassification of existing receivables into subscription-based assets, typically o...

Peer comparison

Common in SaaS and biopharma companies transitioning to recurring service models, often found in the supplemental non-cash disclosures of the cash flow statement.

Metric ID: other_conversion_of_other_receivable_to_subscription_receivable

Historical Data

2 years
 FY'24FY'25
Value$932.00K$0.00
YoY Change-100.0%
Range$0.00$932.00K
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Conversion of other receivable in exchange for research and development services to subscription receivable at Other Companies

Frequently Asked Questions

What is Veradermics 's conversion of other receivable in exchange for research and development services to subscription receivable?
Veradermics (MANE) reported conversion of other receivable in exchange for research and development services to subscription receivable of $0.00 in Q4 2025.
How has Veradermics 's conversion of other receivable in exchange for research and development services to subscription receivable changed year-over-year?
Veradermics 's conversion of other receivable in exchange for research and development services to subscription receivable decreased by 100.0% year-over-year, from $233.00K to $0.00.
What does conversion of other receivable in exchange for research and development services to subscription receivable mean?
The non-cash conversion of outstanding receivables into subscription-based assets.